AKT1 and neoplasm: To confirm that mTOR inhibitors can regulate the level of UBE2C, we extracted proteins from subcutaneous tumor tissues and showed that CCI779 could reduce the level of UBE2C and affect phosphorylated mTOR/AKT/PI3K (Figure 6K).